Dacluzimab is Comparable to Antithymocyte Globulin (ATG) Induction in Preventing Acute Rejection (AR) Episodes in High Risk Renal Transplant Recipients
1999 ◽
Vol 67
(7)
◽
pp. S151
◽
2019 ◽
Vol 51
(4)
◽
pp. 1112-1114
◽
2016 ◽
Vol 89
(5)
◽
pp. 1136-1143
◽
Keyword(s):
2000 ◽
Vol 69
(Supplement)
◽
pp. S114-S115
2000 ◽
Vol 4
(2)
◽
pp. 92-99
◽
2008 ◽
Vol 12
(4)
◽
pp. 474-478
◽
Keyword(s):
2003 ◽
Vol 17
(2)
◽
pp. 151-157
◽
Keyword(s):